Abstract

Highlights From the <i>Circulation</i> Family of Journals

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impact of Cardiac Resynchronization Therapy on Heart Transplant-Free Survival in Pediatric and Congenital Heart Disease Patients
Henry Chubb ... David N Rosenthal
Circulation: Arrhythmia and Electrophysiology | VOL. 13
Henry Chubb, et. al.Henry Chubb ... David N Rosenthal
22 Mar 2020
Echocardiography in selecting pediatric and congenital heart disease patients for resynchronization therapy: a 4 years follow up study
M Al Ahmadi ... W Manea
European Heart Journal | VOL. 34
M Al Ahmadi, et. al.M Al Ahmadi ... W Manea
02 Aug 2013
Response to Abraham
W T Abraham
Circulation | VOL. 114
W T AbrahamW T Abraham
12 Dec 2006
Multicenter Study of Survival Benefit of Cardiac Resynchronization Therapy in Pediatric and Congenital Heart Disease
David M Peng ... Douglas Y Mah
JACC: Clinical Electrophysiology | VOL. 10
David M Peng, et. al.David M Peng ... Douglas Y Mah
10 Jan 2024
View more papers

More From: Circulation

Paper Title
Journal
Date
Author
Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
Shiro Nakamori ... Reza Nezafat
Circulation | VOL. -
Shiro Nakamori, et. al.Shiro Nakamori ... Reza Nezafat
29 May 2024
Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
Shahnawaz Amdani ... Daphne T Hsu
Circulation | VOL. -
Shahnawaz Amdani, et. al.Shahnawaz Amdani ... Daphne T Hsu
29 May 2024
Evolving Cardiac Safety in Drug Discovery: Time for Immunology Integration.
Jose M Vicencio ... Amy Pointon
Circulation | VOL. 149
Jose M Vicencio, et. al.Jose M Vicencio ... Amy Pointon
28 May 2024
Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Peter A Henriksen ... Ninian N Lang
Circulation | VOL. 149
Peter A Henriksen, et. al.Peter A Henriksen ... Ninian N Lang
28 May 2024
View more papers